KINIKSA PHARMACEUTICALS LTD

CUSIP: G5269C101 Class: Foreign Stock

Bank of New York Mellon Corp's Holding History (CIK: 0001390777)

Note: Option positions (PUT/CALL) are excluded.

Q1 2024
Shares 112,580 Value ($000) $2,221 Avg Close Range
Q4 2023
Shares 133,553 Value ($000) $2,343 Avg Close Range
Q3 2023
Shares 146,568 Value ($000) $2,546 Avg Close Range
Q2 2023
Shares 128,778 Value ($000) $1,813 Avg Close Range
Q1 2023
Shares 127,950 Value ($000) $1,377 Avg Close Range
Q4 2022
Shares 127,347 Value ($000) $1,908 Avg Close Range
Q3 2022
Shares 125,528 Value ($000) $1,612 Avg Close Range
Q2 2022
Shares 120,637 Value ($000) $1,170 Avg Close Range
Q1 2022
Shares 137,001 Value ($000) $1,363 Avg Close Range
Q4 2021
Shares 133,906 Value ($000) $1,576 Avg Close Range
Q3 2021
Shares 134,997 Value ($000) $1,537 Avg Close Range
Q2 2021
Shares 131,359 Value ($000) $1,831 Avg Close Range
Q1 2021
Shares 134,415 Value ($000) $2,489 Avg Close Range
Q4 2020
Shares 136,863 Value ($000) $2,418 Avg Close Range
Q3 2020
Shares 90,954 Value ($000) $1,393 Avg Close Range
Q2 2020
Shares 77,517 Value ($000) $1,975 Avg Close Range
Q1 2020
Shares 48,222 Value ($000) $747 Avg Close Range
Q4 2019
Shares 46,224 Value ($000) $512 Avg Close Range
Q3 2019
Shares 52,213 Value ($000) $445 Avg Close Range
Q2 2019
Shares 56,371 Value ($000) $764 Avg Close Range
Q1 2019
Shares 46,944 Value ($000) $848 Avg Close Range
Q4 2018
Shares 20,570 Value ($000) $578 Avg Close Range
Q3 2018
Shares 17,071 Value ($000) $435 Avg Close Range